Literature DB >> 28688954

Rifampicin-induced injury in HepG2 cells is alleviated by TUDCA via increasing bile acid transporters expression and enhancing the Nrf2-mediated adaptive response.

Weiping Zhang1, Lihong Chen2, Hui Feng2, Wei Wang2, Yi Cai2, Fen Qi2, Xiaofang Tao3, Jun Liu3, Yujun Shen3, Xiaofei Ren2, Xi Chen2, Jianming Xu4, Yuxian Shen5.   

Abstract

Bile acid transporters and the nuclear factor erythroid 2-related factor (Nrf-2)-mediated adaptive response play important roles in the development of drug-induced liver injury (DILI). However, little is known about the contribution of the adaptive response to rifampicin (RFP)-induced cell injury. In this study, we found RFP decreased the survival rate of HepG2 cells and increased the levels of lactate dehydrogenase (LDH), alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (AKP), γ-glutamyl-transferase (γ-GT), total bilirubin (TBIL), direct bilirubin (DBIL), indirect bilirubin (IBIL), total bile acid (TBA) and adenosine triphosphate (ATP) in the cell culture supernatants in both a concentration- and a time-dependent manner. RFP increased the expression levels of bile acid transporter proteins and mRNAs, such as bile salt export pump (BSEP), multidrug resistance protein 1 (MDR1), multidrug resistance-associated protein 2 (MRP2), Na+/taurocholate cotransporter (NTCP), organic anion transporting protein 2 (OATP2), organic solute transporter β (OSTβ) and Nrf2. Following the transient knockdown of Nrf2 and treatment with RFP, the expression levels of the BSEP, MDR1, MRP2, NTCP, OATP2 and OSTβ proteins and mRNAs were decreased to different degrees. Moreover, the cell survival was decreased, whereas the LDH level in the cell culture supernatant was increased. Overexpression of the Nrf2 gene produced the opposite effects. Treatment with tauroursodeoxycholic acid (TUDCA) increased the expression levels of the bile acid transporters and Nrf2, decreased the expression levels of glucose-regulated protein 78 (GRP78), PKR-like ER kinase (PERK), activating transcription factor 4 (ATF4), and C/EBP-homologous protein (CHOP), and inhibited RFP-induced oxidative stress. Moreover, TUDCA reduced cell apoptosis, increased cell survival and decreased the levels of LDH, ALT, AST, AKP, γ-GT, TBIL, DBIL, IBIL, TBA and ATP in the cell culture supernatant. Therefore, TUDCA alleviates RFP-induced injury in HepG2 cells by enhancing bile acid transporters expression and the Nrf2-mediated adaptive response.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adaptive response; Bile acid transporters; HepG2 cells; Nrf2; Rifampicin; TUDCA

Mesh:

Substances:

Year:  2017        PMID: 28688954     DOI: 10.1016/j.freeradbiomed.2017.07.003

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  5 in total

1.  A cell lines derived microfluidic liver model for investigation of hepatotoxicity induced by drug-drug interaction.

Authors:  Jiu Deng; Xiuli Zhang; Zongzheng Chen; Yong Luo; Yao Lu; Tingjiao Liu; Zhengzhi Wu; Yu Jin; Weijie Zhao; Bingcheng Lin
Journal:  Biomicrofluidics       Date:  2019-03-07       Impact factor: 2.800

2.  Bile Acid Toxicity and Protein Kinases.

Authors:  Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  TUDCA protects against tunicamycin-induced apoptosis of dorsal root ganglion neurons by suppressing activation of ER stress.

Authors:  Fangyi Chen; Zhe Ge; Nan Li; Zuochong Yu; Rongbo Wu; Yan Zhao; Xianwei He; Guoping Cai
Journal:  Exp Ther Med       Date:  2022-06-10       Impact factor: 2.751

4.  Screening of Biomarkers and Toxicity Mechanisms of Rifampicin-Induced Liver Injury Based on Targeted Bile Acid Metabolomics.

Authors:  Yang Deng; Xilin Luo; Xin Li; Yisha Xiao; Bing Xu; Huan Tong
Journal:  Front Pharmacol       Date:  2022-06-10       Impact factor: 5.988

5.  Mechanisms of Triptolide-Induced Hepatotoxicity and Protective Effect of Combined Use of Isoliquiritigenin: Possible Roles of Nrf2 and Hepatic Transporters.

Authors:  Zhenyan Hou; Lei Chen; Pingfei Fang; Hualin Cai; Huaibo Tang; Yongbo Peng; Yang Deng; Lingjuan Cao; Huande Li; Bikui Zhang; Miao Yan
Journal:  Front Pharmacol       Date:  2018-03-16       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.